European Society of Integrative Medicine

Lue lisää

Lue lisää

Lue lisää


Täydentävät terveysnäkemykset

Täydentävät terveysnäkemykset


Peter Heusser:
"Kehittyvä ihmiskuva ja tiede"

Tiedote (pdf)

Osa I: Tietoteoreettista pohdintaa

Osa II: Antropologista pohdintaaLue lisää


International Society for Complimentary Medicine Research

Lue lisää

Academic Consortium for Integrative Medicine and Health

Lue lisää

Academy of Integrative Health and Medicine

Lue lisää



Peer-reviewed Journals of Research in Integrative Medicine and CAM

Lue lisää.


Lue lisää

Katsaukset ja näkemykset

Opas: “Hyvinvointia ja terveyttä edistävät hoidot Suomessa ja Euroopassa” (Julkaisija: Suomen Terveysjärjestö STJ ry, 2018) Full text (pdf)
Opas pyrkii antamaan vastauksia Suomessa yleisesti käytetyistä täydentävistä hoitomuo- doista. Täydentävät hoitomuodot herättävät paljon tunteita ja usein niiden käyttöön liittyy epätietoisuutta. Oppaan avulla pyritään saamaan aikaan yhteiskunnallista keskustelua siitä, miten näitä hoitoja voitaisiin parhaiten hyödyntää ennaltaehkäisevässä terveydenhoidossa kansalaisten ja koko yhteiskunnan hyväksi. Oppaassa käydään läpi täydentävien hoitojen tilannetta Suomessa ja Euroopassa.

How to Become an Agent of One's Own Healing Processes: Self-Management for Chronically Ill Patients in Integrative Health Care. Berger B. · Heusser P. Complement Med Res 2017;24:202-204 (DOI:10.1159/000479545) (open access:

Complementary and Integrative Medicine and Patient Self-Management of Health. Adams J. Complement Med Res 2017;24:205-206 (DOI:10.1159/000479855 (open access:

The role of complementary and alternative medicine (CAM) in reducing the problem of antimicrobal resistance (November 2015) Full text (pdf)
A new EUROCAM brochure concerning antimicrobial resistance. In a meeting with the EU commission, DG SANCO, last week EUROCAM handed over this brochure. EUROCAM recommends that the potential of CAM in reducing the problem of AMR is given serious consideration and that further research is carried out in this area to determine in which conditions, both in human and veterinary healthcare, specific CAM modalities are particularly effective.

CAM 2020 - The contribution of Complementary and Alternative Medicine to sustainable healthcare in Europe. Full text (pdf)
The booklet "CAM 2020 - The contribution of Complementary and Alternative Medicine to sustainable healthcare in Europe" provides information about CAM scoping its current practice and availability as well as its potential future role across the EU. In addition, it highlights priority policy action areas to enable CAM to fulfil its significant potential to contribute to the healthcare of EU citizens

Complementary & Alternative Medicine: Current status and potential in European healthcare. EUROCAM position paper 2012. (Full text: pdf)

The role of Complementary and Alternative Medicine (CAM) in the context of Cancer EUROCAM position paper 2012. (Full text pdf)

Model Guidelines CAM Practice (CAMDOC 2008) pdf

Integrative Medicine in General Practice (CAMDOC 2011) pdf

Towards Integrative Medicine in Europe CAMDOC-ECIM 2011 pdf



Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers. Skyler B. Johnson, Henry S. Park, Cary P. Gross et al. James B. JAMA Oncol. Published online July 19, 2018. doi:10.1001/jamaoncol.2018.2487

In a retrospective observational study with data from the National Cancer Database on 1 901 815 patients diagnosed with nonmetastatic breast, prostate, lung, or colorectal cancer were investigated whether the use of complementary medicine (CM) was associated with adherence to conventional cancer treatment (CCT) and overall survival. Use of CM was defined as “Other-Unproven: Cancer treatments administered by nonmedical personnel” in addition to at least 1 CCT modality, defined as surgery, radiotherapy, chemotherapy, and/or hormone therapy. Statistical analysis of the data of 258 patients in the CM group and 1 901 557 patients in the control group (no CM used) showed that the CM group were more likely to refuse other conventional cancer treatment and had a higher risk of death than no complementary medicine.

Comment (Peter Zimmermann, MD PhD): The CM group was very small compared to controls and characterized only patients who admitted their use of CM. A significant number of silent CM users may hide in both groups. In addition, many CM users chose CM because they experience more side effects from CCT compared than others. This may also may influence survival. Basic knowledge and training of oncologists in at least some of the evidence based CM modalities would be beneficial to allow the integration of CM into CCT in an individually patient tailoired way. So patients would not have to chose between CM and CCT but rather could use both.